{
  "docId": "019de076-7746-74ba-85f9-63c229edc49f",
  "docSlug": "987f138dade45ff64effcbdaa91cb6f6",
  "documentTitle": "Absci | Investor Presentation Deck | 42 slides",
  "authorId": "absci",
  "authorName": "Absci",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-12-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 42,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "solution",
  "function": "present_solution",
  "density": "sparse",
  "nDataPoints": 0,
  "notes": "The slide uses a process flow diagram to explain the technical methodology.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-7746-74ba-85f9-63c229edc49f/16",
  "deckHref": "/decks/019de076-7746-74ba-85f9-63c229edc49f",
  "deckJsonHref": "/decks/019de076-7746-74ba-85f9-63c229edc49f.json",
  "deckAnchorHref": "/decks/019de076-7746-74ba-85f9-63c229edc49f#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.7,
        "x": 0.15,
        "y": 0.3
      },
      "kind": "diagram",
      "text": "Workflow from target antigen to validated binders",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f62badd-777d-4ea6-9d7f-9ae9b4ff7e8d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.7,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "De novo drug creation with 'zero-shot' generative AI",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dfbf1468-b049-4324-9360-71f97cab3669",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Process flow",
      "slug": "process-flow",
      "agent": null,
      "layer": "slide",
      "matchId": "029f7018-fdb3-497f-8d83-2a6791f7f97f",
      "evidence": "Workflow from target antigen to validated binders",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "327c64a1-8beb-4571-8e89-387547999d3b",
      "evidence": "The slide depicts a sequential workflow from input to output.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 19,
      "from": 12,
      "beatId": "85d24d84-cbb8-4e48-961a-5b0ffbc0677e",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Evidence",
      "beatSlug": "evidence",
      "evidence": "Pages 12-19 provide evidence of Absci's progress and capabilities",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}